Serotonin (5-HT) in the regulation of depression-related emotionality: insight from 5-HT transporter and tryptophan hydroxylase-2 knockout mouse models.

Abstract:

:Disorders of emotion regulation such as anxiety disorders and depression are common and yet debilitating. Accumulating evidence suggests involvement of serotonin (5-HT) in the regulation of emotion. Mice with targeted deletion of genes encoding mediators of the serotonergic transmission have proven to be a powerful tool for understanding contributions of such mediators of emotion regulation. Over the last decade, research on mice with a targeted inactivation of the 5-HT transporter (5-Htt, Sert, Slc6a4) has considerably advanced our knowledge about functions that the 5-HTT plays in the context of emotion related to depression. Moreover, the recent advent of knockout (KO) mice for tryptophan hydroxylase 2 (Tph2 KO), which lacks the rate-limiting enzyme for 5-HT synthesis in the brain, has further provided insight to the brain serotonergic system and its role in emotion dysregulation. Here, we first highlight basic characteristics of the serotonergic system including the biosynthesis of 5-HT as well as the anatomy and firing activity of serotonergic neurons. Furthermore, characteristics of 5-Htt and Tph2 KO mice are covered together with association studies on human variants of 5-HTT and TPH2 in emotional regulation. Among various targets of serotonergic projections, which originate from the raphe nuclei in the brain stem, particular focus is placed on the hippocampus due to its unique dual role in memory and emotion. Finally, effects of therapeutic drugs and psychoactive drugs on KO mouse models as well as on synaptic plasticity will be discussed.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Araragi N,Lesch KP

doi

10.2174/1389450111314050005

subject

Has Abstract

pub_date

2013-05-01 00:00:00

pages

549-70

issue

5

eissn

1389-4501

issn

1873-5592

pii

CDT-EPUB-20130403-3

journal_volume

14

pub_type

杂志文章,评审
  • Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review.

    abstract::The incidence of inflammatory bowel disease (IBD; Crohn's disease, ulcerative colitis) is highest during the peak reproductive years, hence the increased concern with the safety of IBD drugs during pregnancy. Over the past 11 years, anti-TNF-alpha antibody therapy has emerged as a treatment approach for refractory IBD...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010790309885

    authors: El Mourabet M,El-Hachem S,Harrison JR,Binion DG

    更新日期:2010-02-01 00:00:00

  • Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances.

    abstract::Newer classes of medications have been proven useful in glycemic control in type 2 diabetes (T2D), but many do not appear capable to slow down the progressive loss of ß-cell function, or to improve population-level glycemic control. Positive energy balance, e.g. surplus energy intake over expenditure, is at the core f...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666181217111500

    authors: Liu Z,Yang B

    更新日期:2019-01-01 00:00:00

  • PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.

    abstract::PDZ domains play an essential role in a number of cellular processes by facilitating protein scaffolding and assembly of protein complexes. These domains consist of 80 to 90 amino acids and are found to recognize short C-terminal sequences of target proteins. Protein complex formation between PDZ target molecules can ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666141219120125

    authors: Holcomb J,Spellmon N,Trescott L,Sun F,Li C,Yang Z

    更新日期:2015-01-01 00:00:00

  • New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.

    abstract::The etiopathogenesis of Crohn's disease (CD) and ulcerative Colitis (UC), the two major forms of inflammatory bowel disease (IBD), is still unknown. Although the exact cause and mechanisms of both IBD have yet to be completely understood, it is widely accepted that both CD and UC result from an inappropriate immune re...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008784221170

    authors: Stefanelli T,Malesci A,Repici A,Vetrano S,Danese S

    更新日期:2008-05-01 00:00:00

  • The Molecular Concept of Atheromatous Plaques.

    abstract:BACKGROUND:Recently, there are scientific attempts to discover new drugs in the biotechnology industry in order to treat various diseases including atherosclerosis. OBJECTIVE:The main objective of the present review was to highlight the cellular, molecular biology and inflammatory process related to the atheromatous p...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160502151600

    authors: Thent ZC,Chakraborty C,Mahakkanukrauh P,Nik Ritza Kosai Nik Mahmood N,Rajan R,Das S

    更新日期:2017-01-01 00:00:00

  • Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.

    abstract::Classical antidepressant drugs such as Selective Serotonin Reuptake Inhibitors (SSRIs) display several disadvantages, e.g., the onset of action (2 to 3 weeks) to start clinical benefits is too long, and a significant proportion of patients do not respond to this monotherapy. Several strategies have been proposed to ov...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006775515428

    authors: Guiard BP,Lanfumey L,Gardier AM

    更新日期:2006-02-01 00:00:00

  • The deficit in low molecular weight thiols as a target for antiageing therapy.

    abstract::The popular use of antioxidative vitamins illustrates the growing awareness of oxidative stress as an important hazard to our health and as an important factor in the ageing process. Superoxide radicals and superoxide-derived reactive oxygen species (ROS) are constantly formed in most cells and tissues. To ensure that...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450110607011505

    authors: Dröge W,Kinscherf R,Hildebrandt W,Schmitt T

    更新日期:2006-11-01 00:00:00

  • Key targets and relevant inhibitors for the drug discovery of tuberculosis.

    abstract::Tuberculosis (TB) is an infectious disease caused by the pathogen Mycobacterium tuberculosis (M. tuberculosis), killing about two million people worldwide each year. An increase in the prevalence of drug-resistant strains of M. tuberculosis in the past decades has renewed focus on the development of new drugs that can...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314060009

    authors: Xiong X,Xu Z,Yang Z,Liu Y,Wang D,Dong M,Parker EJ,Zhu W

    更新日期:2013-06-01 00:00:00

  • Unique structural motif supports mannosylphospho dolichol synthase: an important angiogenesis regulator.

    abstract::Mannosylphospho dolichol synthase (DPMS) catalyzes the transfer reaction GDP-mannose + Dol-P <--> Dol-P-Man + GDP, a 'key step' in the assembly of lipid-linked oligosaccharide (LLO) and a pre-requisite for asparagine-linked (N-linked) protein glycosylation. DPMS is present from a protozoan parasite to human, and its s...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/138945008783954916

    authors: Baksi K,Tavárez-Pagán JJ,Martínez JA,Banerjee DK

    更新日期:2008-04-01 00:00:00

  • Metal and inflammatory targets for Alzheimer's disease.

    abstract::Alzheimer's disease (AD) has become linked to inflammation and metal biology. Metals (copper, zinc and iron) and inflammatory cytokines are significant factors that increase the onset of sporadic late onset forms of the dementia. The genetic discovery that alleles in the hemochromatosis gene accelerate the onset of di...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043345272

    authors: Rogers JT,Lahiri DK

    更新日期:2004-08-01 00:00:00

  • Recent advances in the discovery of metallo-β-lactamase inhibitors for β-lactam antibiotic-resistant reversing agents.

    abstract::The overuse of antibiotics which exerts the selective pressure for bacterial pathogens has facilitated the spread of antibiotics' resistance. Metallo-β-lactamases (MβLs) are zinc enzymes produced by an increasing number of bacterial pathogens. They can readily cleave carbapenems and most other β-lactams that are mains...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666140326094504

    authors: Guo Z,Ma S

    更新日期:2014-01-01 00:00:00

  • Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications.

    abstract::Cell proliferation, differentiation, and survival are regulated by a number of extracellular hormones, growth factors, and cytokines in complex organisms. The transduction of the signals by these factors from the outside to the nucleus often requires the presence of small intracellular proteins (i.e. ras and other sma...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450053765833

    authors: Caraglia M,Budillon A,Tagliaferri P,Marra M,Abbruzzese A,Caponigro F

    更新日期:2005-05-01 00:00:00

  • Myocardial infarction following atherosclerosis in murine models.

    abstract::The most widely used mouse models for atherosclerosis are LDL receptor knockout (KO) mice and apolipoprotein E (apoE) KO mice fed standard chow diets or lipid-supplemented diets. Unfortunately, these do not usually exhibit myocardial infarction or other features of human cardiovascular disease such as occlusive corona...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008783755566

    authors: Braun A,Rigotti A,Trigatti BL

    更新日期:2008-03-01 00:00:00

  • Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.

    abstract::Cardiovascular diseases (CVD) are the leading cause of death, chronic illness and disability in Western countries. The most common cause of CVD derives from the harmful effects of acute myocardial ischemia and subsequent reperfusion injury. Cardioprotection against acute ischemia/ reperfusion injury is made possible b...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150309115536

    authors: Penna C,Granata R,Tocchetti CG,Gallo MP,Alloatti G,Pagliaro P

    更新日期:2015-01-01 00:00:00

  • Endogenous Enzyme-responsive Nanoplatforms for Anti-tumor Therapy.

    abstract::The emergency of responsive drug delivery systems has contributed to the reduced cytotoxicity, the improved permeability in tissues and extended circulation time of the active drug. Of particular, enzyme-responsive nanoplatforms have attracted a lot due to the specificity and efficiency of an enzyme-catalyzed reaction...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450122666210114095614

    authors: Lou XF,Du YZ,Xu XL

    更新日期:2021-01-13 00:00:00

  • Tachykinins: role in human gastrointestinal tract physiology and pathology.

    abstract::Tachykinins (TKs) and their receptors (NK1, NK2 and NK3), which are diffusely expressed in the human gastrointestinal tract, represent an endogenous modulator system regulating enteric secretomotor functions, inflammatory and immune responses, and visceral hypersensitivity, mainly during pathological gut diseases. Pat...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006778019354

    authors: Improta G,Broccardo M

    更新日期:2006-08-01 00:00:00

  • Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer.

    abstract::While breast cancer (BC) is commonest malignancy among female with highest death rate, male breast cancer (MBC) is very rare but exhibits highest cancer specific death in men and the incidences of MBCs are rising rapidly. Due to rarity of the disease, no detail information about biomarkers and drug targets available a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787122842

    authors: Barh D

    更新日期:2009-01-01 00:00:00

  • HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.

    abstract::Despite the success of combined antiretroviral therapy, more than half of HIV-1-infected patients in the USA show HIV-associated neurological and neuropsychiatric deficits. This is accompanied by anatomical and functional alterations in vulnerable brain regions of the mesocorticolimbic and nigrostriatal systems that r...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150531162212

    authors: Hu XT

    更新日期:2016-01-01 00:00:00

  • Modulation of GABA(A) receptors by natural products and the development of novel synthetic ligands for the benzodiazepine binding site.

    abstract::Nature provides science and society with a virtually unlimited supply of structurally diverse and biologically active molecules; the natural products. While some are directly useful in commercial applications, others are valuable for studying and understanding biological phenomena at the molecular level. An example is...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011798109509

    authors: Nilsson J,Sterner O

    更新日期:2011-10-01 00:00:00

  • TGF-betal/Smad signaling in prostate cancer.

    abstract::Adenocarcinoma of the prostate is the most common type of cancer, excluding skin cancer, and the second leading cause of cancer death in adult men in the United States. The lifetime risk for developing symptomatic prostate cancer is one in five for an American man. A pivotal step in carcinogenesis is a shift in the ba...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450033491118

    authors: Bello-DeOcampo D,Tindall DJ

    更新日期:2003-04-01 00:00:00

  • Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes.

    abstract::Candida species, in particular C. albicans, represent a major threat to immunocompromised patients. Able to exist as a commensal on mucosal surfaces of healthy individuals, these opportunistic fungi frequently cause superficial infections of mucosae and skin. Furthermore, in hospital settings, Candida species may caus...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945005774912735

    authors: Mavor AL,Thewes S,Hube B

    更新日期:2005-12-01 00:00:00

  • The molecular mechanisms of glucocorticoids-mediated neutrophil survival.

    abstract::Neutrophil-dominated inflammation plays an important role in many airway diseases including asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis and cystic fibrosis. In cases of asthma where neutrophil-dominated inflammation is a major contributing factor to the disease, treatment with corticosteroids c...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011794751555

    authors: Saffar AS,Ashdown H,Gounni AS

    更新日期:2011-04-01 00:00:00

  • Aldose reductase, still a compelling target for diabetic neuropathy.

    abstract::Aldose reductase (AR) enzymatically transforms cytosolic glucose into sorbitol, a molecule that poorly penetrates cell membranes and is sometimes slowly metabolized. Hyperglycemia can cause intracellular accumulation of sorbitol and its metabolite, fructose, which can create osmotic swelling and cell dysfunction. Driv...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008783431781

    authors: Oates PJ

    更新日期:2008-01-01 00:00:00

  • Mucosal healing in ulcerative colitis: where do we stand?

    abstract::Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation affecting the colonic mucosa, that can extend to the whole large bowel. The severity of mucosal lesions directly reflects the disease activity and severity and may be prognostic for an aggressive behavior of the pathol...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011796818216

    authors: Fiorino G,Cesarini M,Indriolo A,Malesci A

    更新日期:2011-09-01 00:00:00

  • Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer.

    abstract::Overexpression of the human epidermal growth factor receptor 2 (HER2) is identified in approximately 25- 30% of breast cancers and indicates a poor prognosis. Trastuzumab, the anti-HER2 monoclonal antibody (mAb), has shown significant clinical effects selectively in HER2-overexpressing metastatic breast cancer (MBC) w...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990161

    authors: Huang Y,Fu P,Fan W

    更新日期:2013-07-01 00:00:00

  • Aceruloplasminemia.

    abstract::Ceruloplasmin contains 95% of the copper in human serum and plays an important role in iron efflux from mammalian cells, including brain cells, due to the activity of ferroxidase, which oxidizes ferrous iron following its transfer to the cell surface via the iron transporter, ferroportin, and delivers ferric iron to e...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012802002320

    authors: Kono S

    更新日期:2012-08-01 00:00:00

  • Ubiquitin and Ubiquitin-like proteins in cardiac disease and protection.

    abstract::Post-translational modification represents an important mechanism to regulate protein function in cardiac cells. Ubiquitin (Ub) and ubiquitin-like proteins (UBLs) are a family of protein modifiers that share a certain extent of sequence and structure similarity. Conjugation of Ub or UBLs to target proteins is dynamica...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666151209114608

    authors: Li J,Johnson JA,Su H

    更新日期:2018-01-01 00:00:00

  • The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.

    abstract::At one time, atherosclerosis was thought to be a simple lipid storage disease. However, it is now recognized as a chronic and progressive inflammation of the arterial wall. Gene deletion experiments in murine models of atherosclerosis that reduce the inflammatory process also reduce disease severity. Identifying the i...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007783220605

    authors: Curtiss LK,Tobias PS

    更新日期:2007-12-01 00:00:00

  • Computational function assignment for potential drug targets: from single genes to cellular systems.

    abstract::Biomedical science is currently undergoing an epoch-marking transition from its classical phase to the post-genome era. The outstanding success of world-wide genome sequencing efforts, evidenced by the recent publication of the draft of the human genome, together with the completion of several genomes of eukaryotic mo...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450023347452

    authors: Nagl SB

    更新日期:2002-10-01 00:00:00

  • The Role of Type 2 Fibroblast Growth Factor in Periodontal Therapy.

    abstract::The prevalence of periodontitis is around 20-50% of global population. If not treated, it can cause of tooth loss. Periodontal treatment aims at preserving the patient's teeth from various methods, including infection control and restoring lost periodontal tissue. The periodontium has great biological regenerative pot...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121999201105152639

    authors: Mohammadipour HS,Forouzanfar F,Forouzanfar A

    更新日期:2020-11-05 00:00:00